Drug Type TCR therapy |
Synonyms Super TCR-T EBV ENBA1 (Fanen Bio) |
Target |
Mechanism EBNA1 inhibitors(Epstein-Barr nuclear antigen 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Epstein-Barr virus associated Nasopharyngeal Carcinoma | Preclinical | CN | 17 Aug 2024 |